Article

More than 23,000 people attend AAO annual meeting

New Orleans-More than 23,000 people attended the 2007 annual meeting of the American Academy of Ophthalmology (AAO) Nov. 11 to 13 in New Orleans, according to the organization

New Orleans-More than 23,000 people attended the 2007 annual meeting of the American Academy of Ophthalmology (AAO) Nov. 11 to 13 in New Orleans, according to the organization. The event offered 253 instruction courses, 181 “Breakfast with the Experts” roundtable programs, 91 skills transfer courses, 71 American Academy of Ophthalmic Executives courses, and more than 120 hours of free sessions.

Attendance at the subspecialty day events Nov. 9 and 10 totaled more than 5,800.

Despite numbers being down from last year, when a record-setting 32,574 people registered and 27,249 attended, H. Dunbar Hoskins Jr., MD, AAO executive vice president, said the organization was “very pleased” with participation in the latest meeting and did not regret its decision to proceed with previously made plans to host the meeting in New Orleans after Hurricane Katrina hit the city in 2005.

“We could not have asked for a warmer reception from the people of New Orleans, who went out of their way to make us feel welcome,” he said.

Highlights of the gathering included a keynote address by Judah Folkman, MD, known as the father of angiogenesis; an appearance by Susan Desmond-Hellman, MD, MPH, president of product development for Genentech, at Retina Subspecialty Day to discuss the company’s decision to stop selling bevacizumab (Avastin) to compounding pharmacies; and the participation of more than 600 people in the EyeBuild project to construct houses in residential areas affected by the hurricane.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times) ASCRS 2025: Mark Lobanoff, MD, on making the move to office-based surgery
Barsha Lal, PhD, discusses the way low dose atropine affects accommodative amplitude and dynamics at the 2025 ARVO meeting
(Image credit: Ophthalmology Times) NeuroOp Guru: When eye findings should prompt neuroimaging in suspected neuro-Behcet disease
At the Association for Research in Vision and Ophthalmology (ARVO) meeting, Katherine Talcott, MD, a retina specialist at Cleveland Clinic, shared her findings on EYP-1901 (EyePoint Pharmaceuticals) in the phase 2 DAVIO study.
Dr. Jogin Desai, founder of Eyestem Research, discusses his research at the Association for Research in Vision and Ophthalmology.
(Image credit: Ophthalmology Times) ASCRS 2025: Michael Rivers, MD, shares his takeaways as a panelist at the inaugural SightLine event
(Image credit: Ophthalmology Times) ASCRS 2025: Karl Stonecipher, MD, on LASIK outcomes using an aspheric excimer laser for high myopia
John Tan talks about an emergency triage framework for retinal artery occlusion at the 2025 Association for Research in Vision and Ophthalmology (ARVO) meeting.
Dr Robert Maloney at the 2025 Controversies in Modern Eye Care meeting
Wendy Lee, MD, MS, at Controversies in Modern Eye Care 2025.
© 2025 MJH Life Sciences

All rights reserved.